2019
DOI: 10.1021/acsnano.9b01201
|View full text |Cite
|
Sign up to set email alerts
|

Biodegradable Biliverdin Nanoparticles for Efficient Photoacoustic Imaging

Abstract: Photoacoustic imaging has emerged as a promising imaging platform with a high tissue penetration depth. However, biodegradable nanoparticles, especially those for photoacoustic imaging, are rare and limited to a few polymeric agents. The development of such nanoparticles holds great promise for clinically translatable diagnostic imaging with high biocompatibility. Metabolically digestible and inherently photoacoustic imaging probes can be developed from nanoprecipitation of biliverdin, a naturally occurring he… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
48
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 53 publications
(48 citation statements)
references
References 59 publications
(98 reference statements)
0
48
0
Order By: Relevance
“…Photoacoustic imaging has also emerged as a promising imaging platform with a high tissue penetration depth [69,70]. It applies both NIR laser and ultrasound for the imaging purpose.…”
Section: Imagingmentioning
confidence: 99%
See 3 more Smart Citations
“…Photoacoustic imaging has also emerged as a promising imaging platform with a high tissue penetration depth [69,70]. It applies both NIR laser and ultrasound for the imaging purpose.…”
Section: Imagingmentioning
confidence: 99%
“…Recently, not only polymers, but also natural materials are being engineered as biodegradable imaging agents. Fathi et al have recently developed a photoacoustic imaging nanoprobe from nanoprecipitation of biliverdin, a naturally occurring heme-based pigment, which can be completely biodegraded to biliverdin reductase, a ubiquitous enzyme found in the body [69]. Excitation at near-infrared wavelengths leads to a strong photoacoustic signal, while excitation with ultraviolet wavelengths results in fluorescence emission [69].…”
Section: Imagingmentioning
confidence: 99%
See 2 more Smart Citations
“…To compete efficiently against small‐molecule CAs, nanomaterials must cause negligible biosafety risk after in vivo administration, while furnishing at least one substantial superiority, such as improved resolution, augmented imaging sensitivity, or multiplexing capability 30 . Currently, the representative nanomaterial‐based imaging modalities in clinical settings or preclinical research include MRI, 31 positron emission tomography (PET), 32 single‐photon emission computed tomography, 33 computed tomography (CT), 34 optical fluorescence imaging, 35 PA imaging, 36 and ultrasound (US) imaging 37 …”
Section: Materdicine In Bioimagingmentioning
confidence: 99%